Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study

OBJECTIVE: Elevated lipoprotein(a) [Lp(a)] is a risk factor for atherosclerotic cardiovascular disease (ASCVD) and has no approved pharmacotherapies. Limited real-world data exists on the proportion of patients with available Lp(a) test results, characteristics of these patients, and their use of li...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xingdi, Cristino, Joaquim, Gautam, Raju, Mehta, Rina, Amari, Diana, Heo, Ji Haeng, Wang, Siwei, Wong, Nathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015179/
https://www.ncbi.nlm.nih.gov/pubmed/36936405
http://dx.doi.org/10.1016/j.ajpc.2023.100476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015179/
https://www.ncbi.nlm.nih.gov/pubmed/36936405
http://dx.doi.org/10.1016/j.ajpc.2023.100476

Ejemplares similares